Dermatologi SE

At the 2024 European Academy of Dermatology and Venereology, Dr. Melinda Gooderham presented key findings on deucravacitinib, a new oral treatment for psoriasis. Clinical trials (POETYK PSO-1/PSO-2) showed that more than half of patients improved significantly (PASI 75) by week 16, with sustained results for up to four years. The real-world evidence demonstrated significant reductions in psoriasis severity and improved quality of life after six months of treatment. 🔗Follow along as we uncover highlights from EADV24: https://lnkd.in/dBxhEVh3 #EADV24 #Psoriasis

At the 2024 European Academy of Dermatology and Venereology congress, Dr. Claus Zachariae presented updates on hand eczema treatment. In this MEDtalk, he highlights the recently approved delgocitinib as a promising alternative to previously limited options like steroids and alitretinoin. He also addresses steroid phobia among patients and systemic treatments like methotrexate and dupilumab. 🔗See more from EADV24: https://lnkd.in/dBxhEVh3 #EADV24 #Eczema

Hear Marcela Nowak present a study from EADV 2024 on chronic leg ulcers, highlighting the significance of considering rare diagnoses beyond common vascular causes. While venous insufficiency, atherosclerosis, and diabetic ulcers account for most cases, rare conditions such as pyoderma gangrenosum, vasculitis, neoplasms, and connective tissue diseases were identified in a substantial number of patients. 🔗 Read more about EADV 2024 here: https://lnkd.in/dPFWrSZF #EADV24 #LegUlcers #RareDiagnoses

New research presented at the EADV Congress 2024 shows that perceived stress can directly trigger the relapse of psoriatic skin lesions. The study also highlights the potential of aprepitant in preventing stress-induced psoriasis exacerbations. 🔗 Read more about EADV 2024 here: https://lnkd.in/dPFWrSZF #EADV24 #Psoriasis #Stress

New research unveiled at the European Academy of Dermatology and Venereology Congress 2024 reveals a promising advancement in melanoma detection. This novel method utilisestumour-specific antibodies to identify early-stage melanoma, potentially revolutionising diagnosis and improving patient outcomes by detecting the disease at its most treatable stages. 🔗 See more from EADV 2024: https://lnkd.in/dBxhEVh3 #EADV24 #Melanom

This study presented at EADV 2024 shows that thin melanomas (≤1 mm) have a low risk of metastases (0.2%) and residual melanoma after diagnostic excision. This raises questions about the necessity of wide local excision in such cases, as it may lead to unnecessary treatment. Ebba Wennberg proposes in this MEDtalk a more personalized approach focusing on histopathological margins to reduce unnecessary surgeries and costs. 🔗 Read more about EADV 2024 here: https://lnkd.in/dBxhEVh3 #EADV24 #Melanoma

A study presented Wednesday, 25 September 2024, at the EADV Congress 2024 in Amsterdam highlights the significant potential of semaglutide in treating hidradenitis suppurativa (HS) in obese patients. 🔗 Read more about EADV 2024 here: https://lnkd.in/dBxhEVh3 #EADV24 #HidradenitisSuppurativa

BestPractice Nordic is excited to provide in-depth coverage of the European Academy of Dermatology and Venereology Congress 2024, Europe's largest congress focused on skin and sexual health. The event will take place in Amsterdam from September 25 to 28, offering healthcare professionals the latest updates on dermatology and venereology. 🔗Follow along as we cover EADV 2024: https://lnkd.in/dBxhEVh3 #EADV24 #Dermatology #Venereology

Carsten Sauer Mikkelsen, specialist in dermato-venereologi at Aalborg Universitets Hospital & Aleksandra Lesiak, specialist in dermatology-venereology at the Department of Dermatology, at the Medical University of Lodz, Poland presents: The 4th Scientific Conference of the African Society of Dermatology and Venereology (ASDV) brought together dermatologists from across Africa and beyond to address critical issues in skin care, particularly in African contexts. Topics ranged from dermatological challenges and innovations in skin-of-color dermatology to the unique hair characteristics in African populations and the complexities of treating conditions like Xeroderma Pigmentosa. #ASDV24 #Skindisease

John S. Barbieri presents: Acne is more than just a skin condition; it can lead to significant social stigma. This study explores the extent of stigmatizing attitudes toward individuals with acne, revealing the challenges they might face in relationships, school, and the workplace. #Acne #Skin #Stigma